Virtual Reality Exercise Program for People With Type 2 Diabetes

March 20, 2023 updated by: Dr YU Clare Chung Wah, The Hong Kong Polytechnic University

An E-therapist: An Interactive Immersive Virtual Reality Exercise Program for People With Type 2 Diabetes

The purpose of this study is to examine the effectiveness of a virtual reality (VR) based rehabilitation protocol for improvement of blood glucose control and exercise compliance of patients.

Subjects aged 55-85 diagnosed with Type 2 diabetes will be recruited. A written consent will be obtained from subjects. Subjects recruited will be randomly divided into one of the two groups. The VR group will receive an exercise program conducted in elderly centre or a control group will receive home exercise program. The 12-week exercise program will be conducted three times per week and each session will last for one hour. Assessment that takes about one hour to complete will be carried out at baseline, mid-way (6th week) and after the 12-week exercise training. Assessment items include physical, psychosocial and cognitive function. Also, blood test on HbA1c will be carried out at baseline and at the end of the 12-week training. During this course of research, subjects are strongly advised to stay with their present lifestyle and medication.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Individuals aged between 55 and 80 years with a confirmed diagnosis of type 2 diabetes mellitus (T2DM) and an HbA1c of ≥ 6.5% and ≤ 11%.

Exclusion Criteria:

  • Individuals will be excluded if they have a history of any of the following conditions: cardiac arrest, complex dysrhythmias at rest, complicated myocardial infarction or revascularization procedure, presence of congestive failure, presence of angina, signs or symptoms of post-event myocardial ischemia, renal impairment or proteinuria, hepatic impairment, severe gout or hyperuricemia or uncontrolled hypertension, a fall within the last year, musculoskeletal impairment such as inability to walk independently (after stroke or serious arthritis), neurocognitive disorder, or other diseases that limit their ability to engage in physical activities will be excluded. Individuals enrolled in other physical training programs will also be excluded to ensure any true effect of the proposed intervention can be captured.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immersive Virtual Reality Exercise (IVRE)
VR exercise training for at least three times a week for 12 consecutive weeks (a total of 36 sessions) guided by the e-therapist: The tailored VR-based exercise program involves aerobic and resistance exercises, and VR games.
The IVRE program will include aerobic exercise, muscle strengthening exercise, balance and flexibility exercise.
Active Comparator: Home Exercise
Individuals randomized to the control group will attend a briefing session prior to the start of the program to complete demographic data collection and physical assessment. They will be given an exercise booklet and guided through a set of home-based exercises (identical training to the intervention group except for VR games) in the briefing session. Stepping exercises will be implemented as a substitution of cycling as an aerobic exercise training at home.
Aerobic exercise, muscle strengthening exercise, balance and flexibility exercise at home.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycated Hemoglobin (HbA1C)
Time Frame: Baseline
HbA1c can be used to evaluate how well-controlled blood sugar has been throughout exercise program. Blood tests will be performed by a nurse at the community center and HbA1c tests will be conducted by a private medical laboratory.
Baseline
Glycated Hemoglobin (HbA1C)
Time Frame: 6 weeks
HbA1c can be used to evaluate how well-controlled blood sugar has been throughout
6 weeks
Glycated Hemoglobin (HbA1C)
Time Frame: 12 weeks
HbA1c can be used to evaluate how well-controlled blood sugar has been throughout
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chair Stand Test
Time Frame: Baseline
Testing lower body strength
Baseline
Chair Stand Test
Time Frame: 6 weeks
Testing lower body strength
6 weeks
Chair Stand Test
Time Frame: 12 weeks
Testing lower body strength
12 weeks
Arm Curl Test
Time Frame: Baseline
Testing upper body strength
Baseline
Arm Curl Test
Time Frame: 6 weeks
Testing upper body strength
6 weeks
Arm Curl Test
Time Frame: 12 weeks
Testing upper body strength
12 weeks
Chair Sit and Reach Test
Time Frame: Baseline
Testing lower body flexibility
Baseline
Chair Sit and Reach Test
Time Frame: 6 weeks
Testing lower body flexibility
6 weeks
Chair Sit and Reach Test
Time Frame: 12 weeks
Testing lower body flexibility
12 weeks
Back Scratch Test
Time Frame: Baseline
Testing upper body flexibility
Baseline
Back Scratch Test
Time Frame: 6 weeks
Testing upper body flexibility
6 weeks
Back Scratch Test
Time Frame: 12 weeks
Testing upper body flexibility
12 weeks
8-Foot Up and Go Test
Time Frame: Baseline
Testing agility
Baseline
8-Foot Up and Go Test
Time Frame: 6 weeks
Testing agility
6 weeks
8-Foot Up and Go Test
Time Frame: 12 weeks
Testing agility
12 weeks
Quadriceps strength
Time Frame: Baseline
A handheld dynamometer will be used to assess quadriceps strength.
Baseline
Quadriceps strength
Time Frame: 6 weeks
A handheld dynamometer will be used to assess quadriceps strength.
6 weeks
Quadriceps strength
Time Frame: 12 weeks
A handheld dynamometer will be used to assess quadriceps strength.
12 weeks
Hamstring Strength.
Time Frame: Baseline
A handheld dynamometer will be used to assess hamstring strength.
Baseline
Hamstring Strength.
Time Frame: 6 weeks
A handheld dynamometer will be used to assess hamstring strength.
6 weeks
Hamstring Strength.
Time Frame: 12 weeks
A handheld dynamometer will be used to assess hamstring strength.
12 weeks
Aerobic Capacity
Time Frame: Baseline
The six-minute walk test will be conducted to assess aerobic capacity.
Baseline
Aerobic Capacity
Time Frame: 6 weeks
The six-minute walk test will be conducted to assess aerobic capacity.
6 weeks
Aerobic Capacity
Time Frame: 12 weeks
The six-minute walk test will be conducted to assess aerobic capacity.
12 weeks
Exercise Compliance
Time Frame: Baseline
Participant's compliance to the training program will be measured using Quartrics, a web-based survey system. Participants will receive a verbal reminder from research assistants to attend training sessions.
Baseline
Exercise Compliance
Time Frame: 6 weeks
Participant's compliance to the training program will be measured using Quartrics, a web-based survey system. Participants will receive a verbal reminder from research assistants to attend training sessions.
6 weeks
Exercise Compliance
Time Frame: 12 weeks
Participant's compliance to the training program will be measured using Quartrics, a web-based survey system. Participants will receive a verbal reminder from research assistants to attend training sessions.
12 weeks
Balance
Time Frame: Baseline
The Mini Balance Evaluation Systems Test (Mini-BEST) will be used to assess participant's ability to safely balance during a series of predetermined tasks.
Baseline
Balance
Time Frame: 6 weeks
The Mini Balance Evaluation Systems Test (Mini-BEST) will be used to assess participant's ability to safely balance during a series of predetermined tasks.
6 weeks
Balance
Time Frame: 12 weeks
The Mini Balance Evaluation Systems Test (Mini-BEST) will be used to assess participant's ability to safely balance during a series of predetermined tasks.
12 weeks
Postural sway
Time Frame: Baseline
Postural sway will be evaluated using a force plate, which is an instrument to measure static balance and dynamic balance. Postural sway will be assessed under both eyes opened and closed conditions.
Baseline
Postural sway
Time Frame: 6 weeks
Postural sway will be evaluated using a force plate, which is an instrument to measure static balance and dynamic balance. Postural sway will be assessed under both eyes opened and closed conditions.
6 weeks
Postural sway
Time Frame: 12 weeks
Postural sway will be evaluated using a force plate, which is an instrument to measure static balance and dynamic balance. Postural sway will be assessed under both eyes opened and closed conditions.
12 weeks
Forward Version of Digit-Span Test
Time Frame: Baseline
Forward Version of Digit-Span Test will be used to assess short-term memory. Score ranges from 0 to 14. The higher score indicates the better memory.
Baseline
Forward Version of Digit-Span Test
Time Frame: 6 weeks
Forward Version of Digit-Span Test will be used to assess short-term memory. Score ranges from 0 to 14. The higher score indicates the better memory.
6 weeks
Forward Version of Digit-Span Test
Time Frame: 12 weeks
Forward Version of Digit-Span Test will be used to assess short-term memory. Score ranges from 0 to 14. The higher score indicates the better memory.
12 weeks
Backward Version of Digit-Span Test
Time Frame: Baseline
Backward Version of Digit-Span Test will be used to assess short-term memory. Score ranges from 0 to 14. The higher score indicates the better memory.
Baseline
Backward Version of Digit-Span Test
Time Frame: 6 weeks
Backward Version of Digit-Span Test will be used to assess short-term memory. Score ranges from 0 to 14. The higher score indicates the better memory.
6 weeks
Backward Version of Digit-Span Test
Time Frame: 12 weeks
Backward Version of Digit-Span Test will be used to assess short-term memory. Score ranges from 0 to 14. The higher score indicates the better memory.
12 weeks
Executive Function
Time Frame: Baseline
Wechsler Adult Intelligence Scale Digit-Symbol-Coding will be used to assess the executive function. The score ranges from 0 to 133. The higher score indicate the better executive function.
Baseline
Executive Function
Time Frame: 6 weeks
Wechsler Adult Intelligence Scale Digit-Symbol-Coding will be used to assess the executive function. The score ranges from 0 to 133. The higher score indicate the better executive function.
6 weeks
Executive Function
Time Frame: 12 weeks
Wechsler Adult Intelligence Scale Digit-Symbol-Coding will be used to assess the executive function. The score ranges from 0 to 133. The higher score indicate the better executive function.
12 weeks
Depression
Time Frame: Baseline
The 17-item version of the English and Chinese Diabetes Distress Scale will be used to assess the mental health status. The mean item score ranges from 1 to 6. The mean item score of 3 or above (moderate distress) is considered as the level of distress worthy of clinical attention.
Baseline
Depression
Time Frame: 6 weeks
The 17-item version of the English and Chinese Diabetes Distress Scale will be used to assess the mental health status. The mean item score ranges from 1 to 6. The mean item score of 3 or above (moderate distress) is considered as the level of distress worthy of clinical attention.
6 weeks
Depression
Time Frame: 12 weeks
The 17-item version of the English and Chinese Diabetes Distress Scale will be used to assess the mental health status. The mean item score ranges from 1 to 6. The mean item score of 3 or above (moderate distress) is considered as the level of distress worthy of clinical attention.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Anticipated)

March 31, 2025

Study Completion (Anticipated)

March 31, 2025

Study Registration Dates

First Submitted

March 6, 2023

First Submitted That Met QC Criteria

March 20, 2023

First Posted (Actual)

March 31, 2023

Study Record Updates

Last Update Posted (Actual)

March 31, 2023

Last Update Submitted That Met QC Criteria

March 20, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • P0036522

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be available upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise Therapy

Clinical Trials on Immersive Virtual Reality Exercise (IVRE)

3
Subscribe